Sunshine Biopharma Inc (SBFM)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Sunshine Biopharma Inc

Healthcare (1170)

954-515-0810

333 LAS OLAS WAY, FORT LAUDERDALE

Prossima data di guadagno

Ultimi documenti SEC

SBFM's Discussions on Twitter

Confronta SBFM con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SBFM Sunshine Biopharma Inc	1.50	4.54M	32.96M	-4.23M	-14.00M	-155.33
HLN Haleon Plc Adr	10.80	48.39B	14.35B	1.85B	0	0.4023
ZTS Zoetis Inc	163.04	70.91B	9.29B	2.52B	2.28B	5.57
RDHL Redhill Biopharma Ltd Adr	1.85	3.54M	35.75M	11.57M	-26.25M	-3.8069
TAK Takeda Pharmaceutical Co Adr	14.11	45.20B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	16.94	19.42B	16.54B	-1.64B	749.00M	-1.45

Sunshine Biopharma Inc Borsa (SBFM) Ultime notizie

Sunshine Biopharma Inc Azioni (SBFM) Dati Finanziari

Sunshine Biopharma Inc (SBFM)

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Confronta SBFM con altri titoli

Sunshine Biopharma Inc Borsa (SBFM) Ultime notizie

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year | SBFM Stock News - GuruFocus

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year - ACCESS Newswire

Sunshine Biopharma Reports Double-Digit Growth: Q1 Revenue Jumps 18% as Pipeline Expands with 6 New Drugs - Stock Titan

Sunshine Biopharma (NASDAQ:SBFM) Stock Price Up 8% – Here’s Why - Defense World

Sunshine Biopharma launches generic antipsychotic drug - Investing.com Australia

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia - GuruFocus

Sunshine Biopharma (SBFM) Unveils Generic Antipsychotic Drug in Canada | SBFM Stock News - GuruFocus

Sunshine Biopharma launches generic antipsychotic drug By Investing.com - Investing.com Canada

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market - ACCESS Newswire

Sunshine Biopharma Challenges $1.2B Antipsychotic Market With New Generic Latuda Alternative - Stock Titan

Certain Warrants of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 4-MAY-2025. - marketscreener.com

Sunshine Biopharma Inc’s Market Journey: Closing Weak at 1.84, Down -18.22 - DWinneX

Sunshine Biopharma (NASDAQ:SBFMW) Stock Price Down 4.5% – Here’s Why - Defense World

There is no doubt that Sunshine Biopharma Inc (SBFM) ticks all the boxes. - Sete News

Sunshine Becomes Latest To Compete On Everolimus In Canada - insights.citeline.com

Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug - Asianet Newsable

Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug By Stocktwits - Investing.com India

SBFM Stock: A Comprehensive Analysis and Forecast - investchronicle.com

Sunshine Biopharma enters Canadian generic drug market with Everolimus By Investing.com - Investing.com South Africa

Press Release Distribution & PR Platform - ACCESS Newswire

SBFM’s valuation metrics: A comprehensive analysis - uspostnews.com

Sunshine Biopharma (SBFM) Finalizes $2.46 Million Stock Offering - GuruFocus

Sunshine Biopharma Unit Rolls Out Afinitor Alternative Everolimus in Canadian Market - marketscreener.com

Sunshine Biopharma enters Canadian generic drug market with Everolimus - Investing.com

Sunshine Biopharma (SBFM) Launches Generic Everolimus in Canada | SBFM Stock News - GuruFocus

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion | SBFM Stock News - GuruFocus

Major Cancer Treatment Everolimus Enters Canadian Market: Multiple Cancer Types Targeted in $2.5B Opportunity - Stock Titan

Sunshine Biopharma stock hits 52-week low at $1.24 - Investing.com Australia

Sunshine Biopharma stock hits 52-week low at $1.24 By Investing.com - Investing.com India

Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 10.9% – Here’s Why - Defense World

Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline By Investing.com - Investing.com South Africa

Sunshine Biopharma Closes $2.46 Million Direct Offering - TipRanks

Sunshine Biopharma Secures $2.46 Million in Direct Offering - TipRanks

Sunshine Biopharma Closes $2.5 Million Direct Offering - MarketScreener

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering - ACCESS Newswire

SEC Form 424B5 filed by Sunshine Biopharma Inc. - Quantisnow

Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline - Investing.com India

Sunshine Biopharma’s K1.1-mRNA-LNP shows promise in HCC mouse model - BioWorld MedTech

The time has not yet come to remove your chips from the table: Sunshine Biopharma Inc (SBFM) - Sete News

Sunshine Biopharma secures $2.46 million in stock offering By Investing.com - Investing.com Canada

Sunshine Biopharma Reports 78% Revenue Growth and Key Developments in 2022 - TipRanks

Sunshine Biopharma (SBFM) Reports Increased Revenue Despite Net Loss - GuruFocus

Sunshine Biopharma (SBFM) Secures $2.46 Million in Direct Stock Offering - GuruFocus

Sunshine Biopharma secures $2.46 million in stock offering - Investing.com

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - ACCESS Newswire

Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug - Benzinga

Biotech Stock Sunshine Biopharma Inc. (NASDAQ:SBFM) Makes NASDAQ Top Gainer List on News - Investorideas.com

This Pharma Stock Is Gaining Major Steam Ahead Of Opening Bell - The Globe and Mail

From Underdog to Top Performer: Sunshine Biopharma’s Impressive Surge - timothysykes.com

Sunshine Biopharma (SBFM) Announces Promising Results for Liver Cancer Treatment - GuruFocus

Sunshine Biopharma reports progress in liver cancer treatment - Investing.com India

Sunshine Biopharma Inc Azioni (SBFM) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SBFM